Media

< Back Abingworth Exceeds Target on Latest Life-Sciences Fund

Abingworth Exceeds Target on Latest Life-Sciences Fund

Written by: Asante | Date: 16 July 2018

U.K. life-sciences investor Abingworth said it has closed a new fund with $315 million. The vehicle, Abingworth Bioventures VII LP, exceeded its $300 million target. Placement agent Asante Capital Group helped raise the fund. Abingworth has invested in more than 145 life-sciences companies and raised 12 life-sciences funds since its founding in 1973.

READ FULL ARTICLE ON WSJ PRO